THE INFLUENCE OF A NOVEL PENTADECAPEPTIDE, BPC-157, ON N-G-NITRO-L-ARGININE METHYLESTER AND L-ARGININE EFFECTS ON STOMACH MUCOSA INTEGRITY AND BLOOD-PRESSURE
P. Sikiric et al., THE INFLUENCE OF A NOVEL PENTADECAPEPTIDE, BPC-157, ON N-G-NITRO-L-ARGININE METHYLESTER AND L-ARGININE EFFECTS ON STOMACH MUCOSA INTEGRITY AND BLOOD-PRESSURE, European journal of pharmacology, 332(1), 1997, pp. 23-33
The known effects of a novel stomach pentadecapeptide BPC157 (10 mu g
or 10 ng/kg), namely its salutary activity against ethanol (96%, i.g.)
-induced gastric lesions (simultaneously applied i.p.) and in blood pr
essure maintenance (given i.v.), were investigated in rats challenged
with a combination of N-G-nitro-L-arginine methylester (L-NAME) (5 mg/
kg i.v.), a competitive inhibitor of endothelium nitric oxide (NO)-gen
eration and NO precursor, L-arginine (200 mg/kg i.v.) (D-arginine was
ineffective). In the gastric lesions assay, NO agents were given 5 min
before ethanol injury and BPC 157 medication. Given alone, BPC157 had
an antiulcer effect, as did L-arginine, but L-NAME had no effect. L-N
AME completely abolished the effect of L-arginine, whereas it only att
enuated the effect of BPC 157. After application of the combination of
L-NAME + L-arginine, the BPC157 effect was additionally impaired. In
blood pressure studies, compared with L-arginine, pentadecapeptide BPC
157 (without effect on basal normal values) had both a mimicking effe
ct (impaired L-NAME-blood pressure increase, when applied prophylactic
ally and decreased already raised L-NAME values, given at the time of
the maximal L-NAME-blood pressure increase (i.e., 10 min after L-NAME)
) and preventive activity (L-arginine-induced moderate blood pressure
decrease was prevented by BPC 157 pretreatment). When BPC 157 was give
n 10 min after L-NAME + L-arginine combination, which still led to a b
lood pressure increase, its previously clear effect (noted in L-NAME t
reated rats) disappeared. In vitro, in gastric mucosa from rat stomach
tissue homogenates, BPC 157, given in the same dose (100 mu M) as L-a
rginine, induced a comparable generation of NO. But, BPC 157 effect co
uld not be inhibited by L-NAME, even when L-NAME was given in a tenfol
d (100 versus 1000 mu M) higher dose than that needed for inhibition o
f the L-arginine effect. NO synthesis was blunted when the pentadecape
ptide BPC 157 and L-arginine were combined. In summary, BPC 157 could
interfere with the effects of NO on both gastric mucosal integrity and
blood pressure maintenance in a specific way, especially with L-argin
ine, having a more prominent and/or particularly different effect from
that of NO. (C) 1997 Elsevier Science B.V.